Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1935-1937

  Koks, C H W ^a   Meenhorst, P L ^a   Hillebrand, M J X ^a   Bult, A ^b   Beijnen, J H ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG COMPARISON; DRUG FORMULATION; DRUG SALIVA LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; POWDER; PRIORITY JOURNAL; SUSPENSION; SWALLOWING; THRUSH;

EID: 0029824414     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1935     Document Type: Article

References (10)

1. Baily, G. G., F. M. Perry, D. W. Denning, and B. K. Mandal. 1994. Fluconazole-resistant candidosis in an HIV cohort. AIDS 8:787-792.
2. Brammer, K. W., P. R. Farrow, and J. K. Faulkner. 1990. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12(Suppl. 3):318-326.
3. Force, R. W., and M. C. Nahata. 1995. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann. Pharmacother. 29:10-15.
4. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1039-1047.
5. Koks, C. H. W., H. Rosing, P. L. Meenhorst, A. Bult, and J. H. Beijnen. 1995. High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients. J. Chromatogr. B 663:345-351.
6. Koks, C. H. W., M. H. J. Schepens, D. M. Burger, W. J. M. Underberg, J. W. Mulder, P. L. Meenhorst, and J. H. Beijnen. 1993. Fluconazole in the treatment and prophylaxis of oral candidosis in HIV infected patients. J. Drug Dev. 5:235-249.
7. Newman, S. L., T. P. Flanigan, A. Fisher, M. G. Rinaldi, M. Stein, and K. Vigilante. 1994. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin. Infect. Dis. 19:684-686.
8. Oliary, J., M. Tod, K. Louchahi, O. Petitjean, B. Frachet, V. Le Gros, and N. Brion. 1993. Influence of local radiotherapy on penetration of fluconazole into human saliva. Antimicrob. Agents Chemother. 37:2674-2677.
9. Proost, J. H., and D. K. F. Meijer. 1992. MW/PHARM, an integrated software package for drug dosage regimen calculations and therapeutic drug monitoring. Comput. Biol. Med. 22:155-163.
10. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.